
Basal cell carcinoma (BCC) is a type of skin cancer that develops in the skin's basal cells. Basal cells are found in the lower epidermis, the skin's outer layer. Basal cell carcinoma appears as a tiny, occasionally glossy lump or scaly flat spot on the skin that gradually increases over time.
Basal cell carcinoma typically develops on sun-exposed areas of your body, particularly the head and neck. Basal cell carcinoma can occasionally occur in regions of your body that are usually sheltered from the sun, such as your genitals.
Basal cell carcinoma manifests as a change in the skin, such as a growth or a persistent sore. These changes in the skin (lesions) typically have one of the following characteristics:
Causes
Risk Factors
Factors that increase your risk of basal cell carcinoma include:
Complications
Complications of basal cell carcinoma can include:
To reduce your risk of basal cell carcinoma, you can:
Radiation therapy: Radiation therapy uses high-energy beams, such as X-rays and protons, to kill cancer cells. Radiation therapy is sometimes used after surgery when there is an increased risk that the cancer will return. It might also be used when surgery isn't an option.
Targeted drug therapy: Targeted drug treatments focus on specific weaknesses in cancer cells. By blocking these weaknesses, targeted drug treatments can cause cancer cells to die. Targeted therapy drugs for basal cell carcinoma block molecular signals that keep the cancers growing. They might be considered after other treatments or when other treatments aren't possible.
Cost Start From USD 7500 - USD 12000Explore Options
Chemotherapy: Chemotherapy uses powerful medications to kill cancer cells. It might be an option when other treatments haven't helped.
Cost Start From USD 7420 - USD 30000Explore Options
Medicinal options for Basal Cell Carcinoma (BCC) treatment:









Istanbul, Turkey
The first green hospital in Turkey, Istanbul Florence Nightingale Hospital, was inaugurated in 2013. Group The Florence Nightingale hospitals are the first Turkish hospitals to be granted Joint Commission International (JCI) accreditation, and they continue to be associated and work with esteemed healthcare organizations.
The Florence Nightingale Group treats 250,000 outpatients and 70,000 inpatients annually, demonstrating its excellence. The hospitals have a capacity of 804 inpatient beds, 141 ICU beds, and 40 operating rooms, and perform 20,000+ procedures annually, of which 1,000 are cardiac operations for children and 2,000 are for adults. For conducting difficult orthopedic, general surgery, minimally invasive, and other heart treatments, the facility stands out. All operating rooms can be interconnected by audio-visual to a 300-person conference room and global hubs, enabling interactive medical teaching and scientific activity.
Interpreter and translator services for languages such as Turkish, Azerbaijani, Bulgarian, Arabic, English, Persian, Serbian, Russian, Albanian, Macedonian, German, Bosnian, and Romanian are available.
The hospital has specialized departments such as Cardiology and Cardiac Surgery, IVF and Infertility, Nephrology, Oncology and Oncosurgery, Spine Surgery, Neurology and Neurosurgery, Orthopedics, Gynecology, and Obesity or Bariatric Surgery. With an extensively qualified and experienced team of advisors and interpreters, Florence Nightingale Istanbul is committed to providing one-stop service from beginning to end, 24 hours a day, 7 days a week.

Istanbul, Turkey
Medipol Bahcelievler Hospital is a medical institution providing a full range of medical and individualized approaches to its patients. Medipol has the ambition to bring high quality and maximum security to people in need by employing state-of-the-art technologies in medicine. They ensure that the health of the patients is improved by fashioning unique physician specialty treatment programs.
Medipol Bahcelievler Hospital provides an exceptional position in the healthcare industry with a policy of clear communication, professionalism, and reliability to patient expectations. Medipol Bahçelievler Hospital is situated in the European Side of Istanbul, dedicated to 24-hour health care for you and your loved ones, equipped with a fully functional operation theatre and ICUs with state-of-the-art equipment, laboratory, emergency, and advanced treatment rooms

Istanbul, Turkey
Acibadem Altunizade Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Turkey:
BCC rarely spreads to other parts of the body (metastasising). It is locally invasive, which means it may grow into surrounding tissues but doesn’t typically spread to distant organs.
BCC is highly curable when treated early. Most cases are treated successfully with surgery, with a very low chance of recurrence after proper treatment.
Yes, treating Basal Cell Carcinoma (BCC) using topical medications in Turkey is generally safe, mainly when carried out under the care of a skilled dermatologist. Turkey's hospitals use advanced treatment options and closely monitor patients throughout their therapy. However, the efficacy of topical treatments differs according to the kind and stage of BCC. As a result, patients should consult with an expert professional for personalised treatment.
After treatment, it’s essential to:
Yes, BCC treatment in Turkey is frequently less expensive than in Western countries while maintaining good standards of care.
BCC usually develops slowly over several months or years. It may start as a small, often unnoticed lesion that gradually grows over time, typically in areas exposed to the sun.
In Turkey, risk factors for basal cell carcinoma (BCC) include prolonged sun exposure, pale skin, a history of sunburns, advanced age, male gender, and genetic susceptibility. Occupational UV radiation exposure and immunosuppression, as well as a family history of skin cancer, all enhance the risk.
While BCC is most common in sun-exposed areas like the face, neck, and hands, it can also occur in regions that aren’t directly exposed to the sun, though less frequently.
While sunscreen significantly reduces the risk of developing BCC, it doesn’t eliminate it. Consistent sunscreen use and other sun protection measures (like wearing hats and avoiding peak sun exposure) are essential for lowering risk.
Yes, basal cell carcinoma (BCC) is frequent in Turkey, particularly among those with pale skin who spend much time in the sun. Its prevalence is rising due to increased UV exposure.